BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16194364)

  • 1. [The nuclear factor kappa B activation: the key step of cell proliferation in estrogen receptor-negative breast cancer cells].
    Wang HJ; Wu ZY; Fan P; Bian JM
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):1014-6. PubMed ID: 16194364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.
    Ma G; Tabanca N; Husnu Can Baser K; Kirimer N; Pasco DS; Khan IA; Khan SI
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):673-80. PubMed ID: 18597088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
    Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
    Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.
    Biswas DK; Iglehart JD
    J Cell Physiol; 2006 Dec; 209(3):645-52. PubMed ID: 17001676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the NF-kappa B pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs.
    Monks NR; Pardee AB
    J Cell Biochem; 2006 May; 98(1):221-33. PubMed ID: 16408291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B.
    Rubio MF; Werbajh S; Cafferata EG; Quaglino A; Coló GP; Nojek IM; Kordon EC; Nahmod VE; Costas MA
    Oncogene; 2006 Mar; 25(9):1367-77. PubMed ID: 16331275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
    Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R
    Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth.
    Liu S; Tan WY; Chen QR; Chen XP; Fu K; Zhao YY; Chen ZW
    Cancer Sci; 2008 May; 99(5):952-7. PubMed ID: 18341653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-kappaB in colon cancer cell lines.
    Nakagawa Y; Akao Y
    Exp Cell Res; 2006 Aug; 312(13):2433-42. PubMed ID: 16733051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells.
    Biswas DK; Cruz AP; Gansberger E; Pardee AB
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8542-7. PubMed ID: 10900013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells.
    Shah N; Thomas TJ; Lewis JS; Klinge CM; Shirahata A; Gelinas C; Thomas T
    Oncogene; 2001 Mar; 20(14):1715-29. PubMed ID: 11313919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
    Yang C; Klein EA; Assoian RK; Kazanietz MG
    Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
    Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
    Gionet N; Jansson D; Mader S; Pratt MA
    J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor activates nuclear factor-kappaB in human proximal tubule cells.
    Häussler U; von Wichert G; Schmid RM; Keller F; Schneider G
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F808-15. PubMed ID: 15798085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of polymyxin B on NF-kappaB activation and expression of procollagen I, III in pre-eclamptic umbilical artery smooth muscle cells.
    Jiang RZ; Chen HP; Xu XY
    Chin Med J (Engl); 2006 Mar; 119(5):384-90. PubMed ID: 16542581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The breast cancer cells response to chronic hypoxia involves the opposite regulation of NF-kB and estrogen receptor signaling.
    Scherbakov AM; Lobanova YS; Shatskaya VA; Krasil'nikov MA
    Steroids; 2009 Jun; 74(6):535-42. PubMed ID: 19428442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.